.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Argus Health
US Army
Fuji
Daiichi Sankyo
Moodys
Cipla
Julphar
Cantor Fitzgerald
Cerilliant

Generated: November 22, 2017

DrugPatentWatch Database Preview

Regulatory Exclusivity Expiring in 2023

« Back to Dashboard
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Exclusivity Expiration Patented / Exclusive Use
Eisai Inc
HALAVEN
eribulin mesylate
SOLUTION;INTRAVENOUS201532-001Nov 15, 2010RXYesYes► SubscribeORPHAN DRUG EXCLUSIVITY
Novartis
AFINITOR
everolimus
TABLET;ORAL022334-002Mar 30, 2009RXYesYes► SubscribeORPHAN DRUG EXCLUSIVITY
Novartis
AFINITOR
everolimus
TABLET;ORAL022334-003Jul 9, 2010RXYesNo► SubscribeORPHAN DRUG EXCLUSIVITY
Novartis
AFINITOR
everolimus
TABLET;ORAL022334-004Mar 30, 2012RXYesNo► SubscribeORPHAN DRUG EXCLUSIVITY
Novartis
AFINITOR
everolimus
TABLET;ORAL022334-001Mar 30, 2009RXYesNo► SubscribeORPHAN DRUG EXCLUSIVITY
Pharmacyclics Inc
IMBRUVICA
ibrutinib
CAPSULE;ORAL205552-001Nov 13, 2013RXYesYes► SubscribeORPHAN DRUG EXCLUSIVITY
Spectrum Pharms
EVOMELA
melphalan hydrochloride
POWDER;IV (INFUSION)207155-001Mar 10, 2016RXYesYes► SubscribeORPHAN DRUG EXCLUSIVITY
Pf Prism Cv
XALKORI
crizotinib
CAPSULE;ORAL202570-002Aug 26, 2011RXYesYes► SubscribeORPHAN DRUG EXCLUSIVITY
Pf Prism Cv
XALKORI
crizotinib
CAPSULE;ORAL202570-001Aug 26, 2011RXYesNo► SubscribeORPHAN DRUG EXCLUSIVITY
Jazz Pharms Inc
DEFITELIO
defibrotide sodium
SOLUTION;IV (INFUSION)208114-001Mar 30, 2016RXYesYes► SubscribeORPHAN DRUG EXCLUSIVITY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Moodys
Citi
Mallinckrodt
Baxter
Federal Trade Commission
Queensland Health
Novartis
Fuji
Dow
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot